Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart failure (BASKET).php on line 2
Heart failure (BASKET)
LE WE PMID CA
Heart failure (BASKET)1169Herzinsuffizienz (allg)

Acupuncture

ADH AVP Vasopressin

Adrenomedullin

AQP2

BNP

Glucocorticoids

Heart (Artificial)

Heart (Cardiomyoplasty)

Heart (Echocardiography)

Heart (Imaging)

Heart (MRT)

Heart (Scintigraphy)

Heart failure (acute)

Heart failure (BASKET)

Heart failure (chronical)

Heart failure (Right sided)

Heart failure (Stage D)

Heart pacemaker (biventricular)

Hemodynamic monitoring

Kidney (Anatomy)

Kidney (Principal cells)

Liver (Cirrhosis)

Mineralocorticoids

Mitochondria (BASKET)

Mitochondria (Dysfunction)

NFKB

Nitrosative stress

Oxytocin

PADPR

PARP

Pregnancy (Diseases)

Pulmonary hypertension

Relaxin

Sodium (Hyponatriemia)

T wave alternans

Thyroid (Hypothyreosis)

Tolvaptan

Urocortin

2000  
1
ABC of heart failure. Acute and chronic management strategies.
[10688565] BMJ 320(7234): 559-62 (2000)
2000  
2
ABC of heart failure. Management: digoxin and other inotropes, beta blockers, and antiarrhythmic and antithrombotic treatment.
[10678868] BMJ 320(7233): 495-8 (2000)
2000  
3
ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates.
[10669450] BMJ 320(7232): 428-31 (2000)
2000  
4
ABC of heart failure. Non-drug management.
[10657338] BMJ 320(7231): 366-9 (2000)
2000  
5
ABC of heart failure. Clinical features and complications.
[10642237] BMJ 320(7229): 236-9 (2000)
2000  
6
ABC of heart failure. Pathophysiology.
[10634740] BMJ 320(7228): 167-70 (2000)
2000  
7
ABC of heart failure: aetiology.
[10625270] BMJ 320(7227): 104-7 (2000)
2000  
8
ABC of heart failure. History and epidemiology.
[10617530] BMJ 320(7226): 39-42 (2000)
1999  
9
Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.
[10334754] BMJ 318(7195): 1400-2 (1999)
1994  
10
Diagnosis and management of heart failure.
[7907244] BMJ 308(6924): 321-8 (1994)
2006  
11
Update in the approach to and management of heart failure.
[17233191] South Med J 99(12): 1346-55; quiz 1356-7, 1384 (2006)
2009  
12
High output heart failure.
[18990720] QJM 102(4): 235-41 (2009)
2004  
13
Current concepts in the management of heart failure.
[16563104] Crit Care Resusc 6(1): 31-53 (2004)
2009  
14
Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.
[19168521] Eur J Heart Fail 11(2): 214-9 (2009)
2009  
15
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.
[19214293] Can J Cardiol 25(2): 85-105 (2009)
2008  
16
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.
[18209766] Can J Cardiol 24(1): 21-40 (2008)
1998  
17
Animal models of human cardiovascular disease, heart failure and hypertrophy.
[9764190] Cardiovasc Res 39(1): 60-76 (1998)
2000  
18
The acute vascular effects of frusemide in heart failure.
[10886111] Br J Clin Pharmacol 50(1): 9-13 (2000)
2009  
19
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.
[19586584] Health Technol Assess 13(32): 1-207, iii (2009)
2002  
20
Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death.
[12099324] Am J Manag Care 8(9 Suppl): 18-24 (2002)
2002  
21
Beta blockers as cardioprotective agents: Part I--Insights into mechanisms of action.
[12099323] Am J Manag Care 8(9 Suppl): 13-7 (2002)
1999  
22
Disease management of congestive heart failure.
[10387388] Am J Manag Care 5(4): 499-507; quiz 508-9 (1999)
1998  
23
Clinical practice guidelines for heart failure.
[10184925] Am J Manag Care 4(6 Suppl): S329-37 (1998)
2006  
24
Cardiac resynchronization therapy and adrenergic mechanisms.
[16877559] Am J Physiol Heart Circ Physiol 291(6): H2590-1 (2006)
2009  
25
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
[19487713] Ann Intern Med 150(11): 784-94 (2009)
2007  
26
2005  
27
Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials.
[15657162] Ann Intern Med 142(2): 132-45 (2005)
2001  
28
Beta-blockers in congestive heart failure. A Bayesian meta-analysis.
[11281737] Ann Intern Med 134(7): 550-60 (2001)
2005  
29
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.
[16207349] Arthritis Res Ther 7(5): 195-207 (2005)
1973  
30
Non-invasive methods for the assessment of cardiac function.
[4270111] Calif Med 119(3): 21-37 (1973)
2004  
31
The pulmonary manifestations of left heart failure.
[14769751] Chest 125(2): 669-82 (2004)
2003  
32
Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role.
[12970042] Chest 124(3): 1090-102 (2003)
1998  
33
A review of why and how we may use beta-blockers in congestive heart failure.
[9515860] Chest 113(3): 800-8 (1998)
1986  
34
Prevalence of congestion in chronic heart failure.
[3743140] Chest 90(3): 311-2 (1986)
2009  
35
Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?
[19750134] Circ Heart Fail 2(1): 56-62 (2009)
2003  
36
What is the role of beta-adrenergic signaling in heart failure?
[14615493] Circ Res 93(10): 896-906 (2003)
2008  
37
Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy.
[18711023] Circulation 118(8): 863-71 (2008)
2008  
38
Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective.
[18285578] Circulation 117(7): 975-83 (2008)
2008  
39
New-onset heart failure in children in the absence of structural congenital heart disease.
[18172048] Circulation 117(1): 11-2 (2008)
2007  
40
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
[17630411] Circulation 116(5): e95-8 (2007)
2007  
41
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
[17630410] Circulation 116(5): e99-109 (2007)
2007  
42
Metabolic mechanisms in heart failure.
[17646594] Circulation 116(4): 434-48 (2007)
2006  
43
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
[16785351] Circulation 113(24): 2851-60 (2006)
2006  
44
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
[16702488] Circulation 113(19): 2335-62 (2006)
2005  
45
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America.
[16162914] Circulation 112(12): 1888-916 (2005)
2005  
46
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.
[16160202] Circulation 112(12): e154-235 (2005)
2005  
47
ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America.
[16160201] Circulation 112(12): 1853-87 (2005)
2005  
48
Mechanical device-based methods of managing and treating heart failure.
[16027272] Circulation 112(3): 438-48 (2005)
2005  
49
Mechanisms and models in heart failure: the biomechanical model and beyond.
[15927992] Circulation 111(21): 2837-49 (2005)
2003  
50
Cardiac resynchronization therapy for heart failure.
[14638522] Circulation 108(21): 2596-603 (2003)
2003  
51
How do beta-blockers improve ventricular function in patients with congestive heart failure?
[12756189] Circulation 107(19): 2395-7 (2003)
2003  
52
Antiadrenergic therapy of chronic heart failure: surprises and new opportunities.
[12615784] Circulation 107(8): 1100-2 (2003)
2002  
53
Sympathetic nervous system in heart failure.
[12417535] Circulation 106(19): 2417-8 (2002)
2002  
54
Contemporary medical options for treating patients with heart failure.
[12010904] Circulation 105(19): 2244-6 (2002)
2002  
55
New therapeutic options in congestive heart failure: Part II.
[11994259] Circulation 105(18): 2223-8 (2002)
2002  
56
New therapeutic options in congestive heart failure: Part I.
[11980691] Circulation 105(17): 2099-106 (2002)
2002  
57
The "unsympathetic" nervous system of heart failure.
[11956112] Circulation 105(15): 1753-5 (2002)
2001  
58
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.
[11739319] Circulation 104(24): 2996-3007 (2001)
2000  
59
Catecholamines, cardiac beta-adrenergic receptors, and heart failure.
[10758041] Circulation 101(14): 1634-7 (2000)
2000  
60
beta-adrenergic receptor blockade in chronic heart failure.
[10662755] Circulation 101(5): 558-69 (2000)
1999  
61
Mechanisms and models in heart failure: A combinatorial approach.
[10468532] Circulation 100(9): 999-1008 (1999)
1998  
62
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.
[9743509] Circulation 98(12): 1184-91 (1998)
2008  
63
Evolving concepts of left ventricular hypertrophy.
[18337237] Eur Heart J 29(7): 846-8 (2008)
2008  
64
Heart failure with preserved ejection fraction: dangerous, elusive, and difficult.
[18202254] Eur Heart J 29(3): 285-7 (2008)
2006  
65
Heart failure therapy: testosterone replacement and its implications.
[16291772] Eur Heart J 27(1): 10-2 (2006)
2005  
66
The importance of the gastrointestinal system in the pathogenesis of heart failure.
[15980032] Eur Heart J 26(22): 2368-74 (2005)
2005  
67
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
[15901669] Eur Heart J 26(11): 1115-40 (2005)
2004  
68
Expert consensus document on beta-adrenergic receptor blockers.
[15288162] Eur Heart J 25(15): 1341-62 (2004)
2001  
69
Refractory heart failure - drugs and devices.
[11728141] Eur Heart J 22(24): 2227-30 (2001)
2000  
70
The 6-minute walk. A simple test with clinical application.
[10775001] Eur Heart J 21(7): 507-8 (2000)
2000  
71
Beta-blockers continue to surprise us.
[10666349] Eur Heart J 21(5): 354-64 (2000)
1999  
72
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
[10448027] Eur Heart J 20(16): 1182-90 (1999)
1997  
73
The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.
[9152644] Eur Heart J 18(5): 736-53 (1997)
1997  
74
Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials.
[9129883] Eur Heart J 18(4): 560-5 (1997)
1996  
75
Beta-blocking agents in heart failure. Should they be used and how?
[8922910] Eur Heart J 17(11): 1629-39 (1996)
1996  
76
Congestive heart failure. Towards a comprehensive treatment.
[8733071] Eur Heart J 17 Suppl B(-): 43-56 (1996)
1996  
77
Beta-blockers in heart failure. Future directions.
[8733070] Eur Heart J 17 Suppl B(-): 39-42 (1996)
1996  
78
Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
[8733068] Eur Heart J 17 Suppl B(-): 24-9 (1996)
1996  
79
Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the disease.
[8733067] Eur Heart J 17 Suppl B(-): 21-3 (1996)
1996  
80
Beta-blockers in heart failure--the evidence from clinical trials.
[8733066] Eur Heart J 17 Suppl B(-): 17-20 (1996)
1996  
81
Cardiac adrenergic receptor effects of carvedilol.
[8733065] Eur Heart J 17 Suppl B(-): 8-16 (1996)
2006  
82
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients.
[16339814] Heart 92(12): 1728-31 (2006)
2005  
83
Systematic review of multidisciplinary interventions in heart failure.
[15958358] Heart 91(7): 899-906 (2005)
2002  
84
Heart failure: aetiology, diagnosis, and treatment.
[12433879] Heart 88(6): 567-9 (2002)
2001  
85
Heart failure: What causes the symptoms of heart failure?
[11602559] Heart 86(5): 574-8 (2001)
2001  
86
Heart Failure: Treatment strategies for heart failure: beta blockers andantiarrhythmics.
[11119476] Heart 85(1): 97-103 (2001)
2000  
87
Non-transplant surgery for heart failure.
[10768919] Heart 83(5): 603-10 (2000)
2000  
88
Epidemiology, aetiology, and prognosis of heart failure.
[10768918] Heart 83(5): 596-602 (2000)
1999  
89
Major beta blocker mortality trials in chronic heart failure: a critical review.
[10574906] Heart 82 Suppl 4(-): IV14-22 (1999)
1997  
90
The origin of symptoms in chronic heart failure.
[9414998] Heart 78(5): 429-30 (1997)
2006  
91
Novel mechanisms of sympathetic regulation in chronic heart failure.
[17015773] Hypertension 48(6): 1005-11 (2006)
2009  
92
Adherence to guidelines improves the clinical outcome of patients with acutely decompensated heart failure.
[19697585] Isr Med Assoc J 11(6): 348-53 (2009)
2009  
93
2003  
94
Cardiac resynchronization therapy for heart failure shows great promise.
[12929300] Isr Med Assoc J 5(8): 589-91 (2003)
2008  
95
Anemia and mortality in heart failure patients a systematic review and meta-analysis.
[18755344] J Am Coll Cardiol 52(10): 818-27 (2008)
2008  
96
Anemia and chronic heart failure implications and treatment options.
[18687241] J Am Coll Cardiol 52(7): 501-11 (2008)
2008  
97
Vasodilator therapy for decompensated heart failure.
[18617069] J Am Coll Cardiol 52(3): 208-10 (2008)
2007  
98
Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis.
[17062772] J Clin Endocrinol Metab 92(1): 180-5 (2007)
2005  
99
Altered intracellular Ca2+ handling in heart failure.
[15765137] J Clin Invest 115(3): 556-64 (2005)
2005  
100
Mitochondrial energy metabolism in heart failure: a question of balance.
[15765136] J Clin Invest 115(3): 547-55 (2005)
2005  
101
Genetic causes of human heart failure.
[15765133] J Clin Invest 115(3): 518-26 (2005)
2005  
102
NO/redox disequilibrium in the failing heart and cardiovascular system.
[15765132] J Clin Invest 115(3): 509-17 (2005)
2005  
103
Oxygen, oxidative stress, hypoxia, and heart failure.
[15765131] J Clin Invest 115(3): 500-8 (2005)
2005  
104
Learning from failure: congestive heart failure in the postgenomic age.
[15765130] J Clin Invest 115(3): 495-9 (2005)
2001  
105
Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown.
[11306597] J Clin Invest 107(8): 947-8 (2001)
1993  
106
Beta-adrenergic receptors in heart failure.
[8254011] J Clin Invest 92(6): 2564 (1993)
2009  
107
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
[19176440] JAMA 301(4): 383-92 (2009)
2002  
108
beta-Blockers in heart failure: clinical applications.
[11851583] JAMA 287(7): 890-7 (2002)
2002  
109
beta-Blocker therapy in heart failure: scientific review.
[11851582] JAMA 287(7): 883-9 (2002)
2002  
110
Medical management of advanced heart failure.
[11829703] JAMA 287(5): 628-40 (2002)
1997  
111
Arrhythmias and sudden death in heart failure.
[9293402] Jpn Circ J 61(9): 727-40 (1997)
2000  
112
2005  
113
Aldosterone receptor antagonists in the medical management of chronic heart failure.
[16342656] Mayo Clin Proc 80(12): 1623-30 (2005)
2002  
114
Beta-blockers in chronic heart failure: considerations for selecting an agent.
[12440556] Mayo Clin Proc 77(11): 1199-206 (2002)
2002  
115
Beta-blockers: new standard therapy for heart failure.
[12173717] Mayo Clin Proc 77(8): 839-45; quiz 845-6 (2002)
2004  
116
Use of diuretics in cardiovascular diseases: (1) heart failure.
[15082840] Postgrad Med J 80(942): 201-5 (2004)
2003  
117
Drug therapy in chronic heart failure.
[14654574] Postgrad Med J 79(937): 634-42 (2003)
2003  
118
Mechanisms and management of diuretic resistance in congestive heart failure.
[12782772] Postgrad Med J 79(931): 268-71 (2003)
1998  
119
Recent advances in the drug treatment of heart failure.
[10197196] Postgrad Med J 74(877): 658-61 (1998)
1997  
120
The management of congestive heart failure.
[9156120] Postgrad Med J 73(858): 194-200 (1997)
1996  
121
Diagnosis and management of heart failure in the elderly.
[8977936] Postgrad Med J 72(852): 577-80 (1996)
2006  
122
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.
[16980725] Rheumatology (Oxford) 45 Suppl 4(-): iv8-13 (2006)
2007  
123
1999  
124
Pathophysiology of heart failure: a look at the future.
[10217468] Tex Heart Inst J 26(1): 28-33 (1999)
1999  
125
1991  
126
Congestive heart failure. New frontiers.
[1678903] West J Med 154(4): 427-41 (1991)
1990  
127
Managing congestive heart failure medically--what have we learned?
[2244381] West J Med 153(4): 442-4 (1990)
1990  
128
Medical management of congestive heart failure.
[2244376] West J Med 153(4): 406-14 (1990)
2007  
129
The challenge of correcting volume overload in hospitalized patients with decompensated heart failure.
[17291933] J Am Coll Cardiol 49(6): 684-6 (2007)
2006  
130
Emerging therapies for the management of decompensated heart failure: from bench to bedside.
[17174176] J Am Coll Cardiol 48(12): 2397-409 (2006)
2005  
131
Ultrafiltration: a new approach toward mechanical diuresis in heart failure.
[16325041] J Am Coll Cardiol 46(11): 2052-3 (2005)
2005  
132
Vasopressin antagonism in heart failure.
[16286160] J Am Coll Cardiol 46(10): 1785-91 (2005)
2004  
133
Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
[15364337] J Am Coll Cardiol 44(6): 1308-10 (2004)
2004  
134
Anemia as a risk factor and therapeutic target in heart failure.
[15337204] J Am Coll Cardiol 44(5): 959-66 (2004)
2004  
135
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.
[15013109] J Am Coll Cardiol 43(3): 317-27 (2004)
2003  
136
Predicting cardiac resynchronization response by QRS duration: the long and short of it.
[14680738] J Am Coll Cardiol 42(12): 2125-7 (2003)
2003  
137
Colloid osmotic pressure: an under-recognized factor in the clinical syndrome of heart failure.
[12932608] J Am Coll Cardiol 42(4): 717-8 (2003)
2002  
138
The regulation and measurement of plasma volume in heart failure.
[12084586] J Am Coll Cardiol 39(12): 1901-8 (2002)
2001  
139
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).
[11738322] J Am Coll Cardiol 38(7): 2101-13 (2001)
2001  
140
Heart failure with preserved systolic function. A different natural history?
[11691495] J Am Coll Cardiol 38(5): 1277-82 (2001)
2000  
141
The role of tumor necrosis factor in the pathophysiology of heart failure.
[10716453] J Am Coll Cardiol 35(3): 537-44 (2000)
1999  
142
1998  
143
Etiology and response to drug treatment in heart failure.
[9809921] J Am Coll Cardiol 32(5): 1167-72 (1998)
1997  
144
Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.
[9207617] J Am Coll Cardiol 30(1): 27-34 (1997)
1995  
145
Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).
[7594057] J Am Coll Cardiol 26(5): 1376-98 (1995)
1987  
146
Renal and circulatory mechanisms in congestive heart failure.
[2956452] Kidney Int 31(6): 1402-15 (1987)
1998  
147
The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review).
[9852194] Int J Mol Med 1(1): 17-24 (1998)
2002  
148
The B-type natriuretic peptide assay: a rapid test for heart failure.
[11890215] Cleve Clin J Med 69(3): 243-51 (2002)
2007  
149
Heart failure in women is different than in men; should treatment be different?
[17569200] Cleve Clin J Med 74(6): 423-4, 426, 429-35 (2007)
2004  
150
Cellular basis for therapeutic choices in heart failure.
[15505109] Circulation 110(17): 2559-61 (2004)
2005  
151
Urocortin: advancing the neurohumoral hypothesis of heart failure.
[16330694] Circulation 112(23): 3544-6 (2005)
2011  
152
How to treat stage D heart failure? - When to implant left ventricular assist devices in the era of continuous flow pumps?-.
[21817817] Circ J 75(9): 2038-45 (2011)
2011  
153
Careful echocardiographic analysis of right ventricular function as a long-term prognostic variable in systolic heart failure.
[21817818] Circ J 75(9): 2054-5 (2011)
2010  
154
The future of pharmacological therapy for heart failure.
[20424329] Circ J 74(5): 809-17 (2010)
2010  
155
Waon therapy for cardiovascular disease: innovative therapy for the 21st century.
[20154403] Circ J 74(4): 617-21 (2010)
2009  
156
Global gene expression profiling in the failing myocardium.
[19638707] Circ J 73(9): 1568-76 (2009)
2011  
157
Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.
[21274403] J Biomed Biotechnol 2011(-): 729497 (2011)
2010  
158
Mitochondria in heart failure.
[20668004] Cardiovasc Res 88(1): 40-50 (2010)
2008  
159
Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?
[18006486] Cardiovasc Res 77(2): 302-14 (2008)
2008  
160
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.
[18349024] Eur Heart J 29(9): 1147-59 (2008)
2008  
161
Modulation of cardiac contractility. A potential treatment of heart failure?
[18367493] Eur Heart J 29(8): 961-3 (2008)
2006  
162
Sudden death prevention in heart failure.
[17069438] Rev Port Cardiol 25(7-8): 727-62 (2006)
2004  
163
Energy metabolism in heart failure.
[14660709] J Physiol 555(Pt 1): 1-13 (2004)
2008  
164
Beta blockers in systolic heart failure.
[18345362] Aust Fam Physician 37(3): 137-9 (2008)
2007  
165
2007  
166
Magnetic resonance imaging of the failing heart.
[17679350] Scand J Surg 96(2): 102-6 (2007)
2010  
167
New biomarkers in heart failure: applications in diagnosis, prognosis and guidance of therapy.
[20515620] Rev Esp Cardiol 63(6): 635-9 (2010)
2011  
168
Prognosis for patients with heart failure with preserved ejection fraction. Is it the same as low ejection fraction?
[21723656] Rev Esp Cardiol 64(8): 646-8 (2011)
2009  
169
Cardiovascular translational medicine (III). Genomics and proteomics in heart failure research.
[19268076] Rev Esp Cardiol 62(3): 305-13 (2009)
2008  
170
Vasopressin and aquaporin 2 in clinical disorders of water homeostasis.
[18519089] Semin Nephrol 28(3): 289-96 (2008)
2007  
171
Utility of T-wave alternans in congestive heart failure.
[17584689] Anadolu Kardiyol Derg 7 Suppl 1(-): 82-4 (2007)
2011  
172
Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.
[20797985] Cardiovasc Res 89(1): 129-38 (2011)
2010  
173
2004  
174
New diagnostic modalities in the diagnosis of heart failure.
[15586645] J Natl Med Assoc 96(11): 1424-30 (2004)
2002  
175
Benefits of beta-blocker therapy for heart failure: weighing the evidence.
[11911717] Arch Intern Med 162(6): 641-8 (2002)
2010  
176
Molecular forms of natriuretic peptides in heart failure and their implications.
[19451138] Heart 96(6): 419-24 (2010)
2005  
177
Nitrosative stress and pharmacological modulation of heart failure.
[15925705] Trends Pharmacol Sci 26(6): 302-10 (2005)
2009  
178
Towards a better risk stratification for sudden cardiac death in patients with structural heart disease.
[19325901] Neth Heart J 17(3): 101-6 (2009)
2007  
179
Therapies for heart failure: a report from the Heart Failure Congress 2007.
[18297144] Timely Top Med Cardiovasc Dis 11(-): E16 (2007)
2010  
180
Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy.
[21142628] Future Cardiol 6(6): 743-7 (2010)
2008  
181
Ventricular-vascular interaction in heart failure.
[18313622] Heart Fail Clin 4(1): 23-36 (2008)
2009  
182
Natriuretic peptides in the diagnosis and management of chronic heart failure.
[19631175] Heart Fail Clin 5(4): 501-14 (2009)
2009  
183
Ion channels, transporters, and pumps as targets for heart failure therapy.
[19365280] J Cardiovasc Pharmacol 54(4): 273-8 (2009)
2008  
184
The future of cardiovascular imaging in the diagnosis and management of heart failure, part 1: tasks and tools.
[19808515] Circ Cardiovasc Imaging 1(1): 58-69 (2008)
2010  
185
A comprehensive noninvasive hemodynamic assessment of systolic heart failure.
[20484194] Circ Heart Fail 3(3): 337-9 (2010)
2009  
186
Small animal models of heart failure: development of novel therapies, past and present.
[19808329] Circ Heart Fail 2(2): 138-44 (2009)
2009  
187
Heart failure in children: part II: diagnosis, treatment, and future directions.
[19808380] Circ Heart Fail 2(5): 490-8 (2009)
2009  
188
Pharmacological treatment for heart failure: a view from the brain.
[19553933] Clin Pharmacol Ther 86(2): 216-20 (2009)
2011  
189
Electrical modalities beyond pacing for the treatment of heart failure.
[21104313] Heart Fail Rev 16(3): 315-25 (2011)
2009  
190
Relaxin, a pleiotropic vasodilator for the treatment of heart failure.
[19101795] Heart Fail Rev 14(4): 321-9 (2009)
2007  
191
Educational settings in the management of patients with heart failure.
[17546370] Rev Lat Am Enfermagem 15(2): 344-9 (2007)
2010  
192
Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.
[21694929] Int J Nephrol Renovasc Dis 3(-): 51-60 (2010)
2003  
193
2010  
194
Relaxin: review of biology and potential role in treating heart failure.
[20424993] Curr Heart Fail Rep 7(2): 75-82 (2010)
2010  
195
Advances in systolic heart failure.
[20948854] F1000 Med Rep 2(-): - (2010)
2010  
196
Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
[20820751] J Mol Med (Berl) 88(10): 1011-20 (2010)
2009  
197
Regulation of mitochondrial Ca2+ and its effects on energetics and redox balance in normal and failing heart.
[19390955] J Bioenerg Biomembr 41(2): 127-32 (2009)
2011  
198
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.
[21138935] Eur Heart J 32(6): 670-9 (2011)
PMC   
199
Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.
[23152112] Am J Physiol Regul Integr Comp Physiol 304(2):R102-9 (2013)
PMC   
200
Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure.
[24459600] Cardiol Res Pract 2013():824135 (2013)
PMC   
201
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
[23221478] Channels (Austin) 7(1):17-22 (2013)
PMC   
202
Congestive heart failure: experimental model.
[24400279] Front Pediatr 1():33 (2013)
PMC   
203
Preoperative usages of levosimendan in patients undergoing coronary artery bypass grafting.
[24482709] Int J Clin Exp Med 7(1):219-29 (2014)
PMC   
204
Urinary C-type natriuretic peptide: a new heart failure biomarker.
[24244916] JACC Heart Fail 1(2):170-7 (2013)
PMC   
205
Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.
[24494189] Redox Biol 2():148-55 (2014)
PMC   
206
H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.
[23393010] Circulation 127(10):1116-27 (2013)
PMC   
207
Nitric oxide synthases in heart failure.
[22871241] Antioxid Redox Signal 18(9):1078-99 (2013)
PMC   
208
Advances in the surgical treatment of heart failure.
[18382214] Curr Opin Cardiol 23(3):249-53 (2008)
PMC   
209
Multi-marker strategies in heart failure: clinical and statistical approaches.
[19412735] Heart Fail Rev 15(4):343-9 (2010)
PMC   
210
American Heart Association Scientific Sessions 2013: Agents for Hypertension, Heart Failure, and Acute Myocardial Infarction.
[24672217] P T 39(1):65-7 (2014)
PMC   
211
A new twist on an old idea: a two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction.
[24744855] Physiol Rep 1(7): (2013)
PMC   
212
Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.
[22964268] Biochim Biophys Acta 1833(4):840-7 (2013)
PMC   
213
Regulatory role of regucalcin in heart calcium signaling: Insight into cardiac failure (Review).
[24748964] Biomed Rep 2(3):303-308 (2014)
PMC   
214
Liver complications in patients with congestive heart failure.
[24711770] Gastroenterol Hepatol (N Y) 9(4):244-6 (2013)
PMC   
215
Heart rate reduction: an old and novel candidate heart failure therapy.
[22493078] Hypertension 59(5):908-10 (2012)
PMC   
216
Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.
[21723628] Int J Cardiol 151(2):237-9 (2011)
PMC   
217
Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.
[23582087] J Card Fail 19(4):219-24 (2013)
PMC   
218
Development and course of heart failure after a myocardial infarction in younger and older people.
[24748875] J Geriatr Cardiol 11(1):1-12 (2014)
PMC   
219
Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function.
[19560697] J Heart Lung Transplant 28(7):689-96 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart failure (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart failure (BASKET).php on line 92